174 related articles for article (PubMed ID: 31221668)
1. Development of mouse models of angiosarcoma driven by p53.
Salter DM; Griffin M; Muir M; Teo K; Culley J; Smith JR; Gomez-Cuadrado L; Matchett K; Sims AH; Hayward L; Henderson NC; Brunton VG
Dis Model Mech; 2019 Jul; 12(7):. PubMed ID: 31221668
[TBL] [Abstract][Full Text] [Related]
2. Genetic context of oncogenic drivers dictates vascular sarcoma development in aP2-Cre mice.
Hanna JA; Langdon CG; Garcia MR; Benton A; Lanman NA; Finkelstein D; Rehg JE; Hatley ME
J Pathol; 2022 May; 257(1):109-124. PubMed ID: 35066877
[TBL] [Abstract][Full Text] [Related]
3. A Trp53fl/flPtenfl/fl mouse model of undifferentiated pleomorphic sarcoma mediated by adeno-Cre injection and in vivo bioluminescence imaging.
Buchakjian MR; Merritt NM; Moose DL; Dupuy AJ; Tanas MR; Henry MD
PLoS One; 2017; 12(8):e0183469. PubMed ID: 28841687
[TBL] [Abstract][Full Text] [Related]
4. Pdgfrb-Cre targets lymphatic endothelial cells of both venous and non-venous origins.
Ulvmar MH; Martinez-Corral I; Stanczuk L; Mäkinen T
Genesis; 2016 Jun; 54(6):350-8. PubMed ID: 27060598
[TBL] [Abstract][Full Text] [Related]
5. p53 mutation and loss have different effects on tumourigenesis in a novel mouse model of pleomorphic rhabdomyosarcoma.
Doyle B; Morton JP; Delaney DW; Ridgway RA; Wilkins JA; Sansom OJ
J Pathol; 2010 Oct; 222(2):129-37. PubMed ID: 20662002
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Pdgfrb-Cre transgenic mice reveals reduction of ROSA26 reporter activity in remodeling arteries.
Cuttler AS; LeClair RJ; Stohn JP; Wang Q; Sorenson CM; Liaw L; Lindner V
Genesis; 2011 Aug; 49(8):673-80. PubMed ID: 21557454
[TBL] [Abstract][Full Text] [Related]
7. Mutant p53 regulates Survivin to foster lung metastasis.
Tang Q; Efe G; Chiarella AM; Leung J; Chen M; Yamazoe T; Su Z; Pitarresi JR; Li J; Islam M; Karakasheva T; Klein-Szanto AJ; Pan S; Hu J; Natsugoe S; Gu W; Stanger BZ; Wong KK; Diehl JA; Bass AJ; Nakagawa H; Murphy ME; Rustgi AK
Genes Dev; 2021 Apr; 35(7-8):528-541. PubMed ID: 33737385
[TBL] [Abstract][Full Text] [Related]
8. Single-Cell Analysis Differentiates the Effects of p53 Mutation and p53 Loss on Cell Compositions of Oncogenic Kras-Driven Pancreatic Cancer.
Sun X; Yang D; Chen Y
Cells; 2023 Nov; 12(22):. PubMed ID: 37998349
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the Two Inducible Cre Recombinase-Based Mouse Models NG2-CreER™ and PDGFRb-P2A-CreER
Mayr D; Preishuber-Pflügl J; Koller A; Brunner SM; Runge C; Ladek AM; Rivera FJ; Reitsamer HA; Trost A
Curr Eye Res; 2022 Apr; 47(4):590-596. PubMed ID: 34758271
[TBL] [Abstract][Full Text] [Related]
10. Mutant p53 Promotes Epithelial Ovarian Cancer by Regulating Tumor Differentiation, Metastasis, and Responsiveness to Steroid Hormones.
Ren YA; Mullany LK; Liu Z; Herron AJ; Wong KK; Richards JS
Cancer Res; 2016 Apr; 76(8):2206-18. PubMed ID: 26964623
[TBL] [Abstract][Full Text] [Related]
11. Smad4 and p53 synergize in suppressing autochthonous intestinal cancer.
Park JW; Seo MJ; Cho KS; Kook MC; Jeong JM; Roh SG; Cho SY; Cheon JH; Kim HK
Cancer Med; 2022 May; 11(9):1925-1936. PubMed ID: 35274815
[TBL] [Abstract][Full Text] [Related]
12. SETDB1 Inhibits p53-Mediated Apoptosis and Is Required for Formation of Pancreatic Ductal Adenocarcinomas in Mice.
Ogawa S; Fukuda A; Matsumoto Y; Hanyu Y; Sono M; Fukunaga Y; Masuda T; Araki O; Nagao M; Yoshikawa T; Goto N; Hiramatsu Y; Tsuda M; Maruno T; Nakanishi Y; Hussein MS; Tsuruyama T; Takaori K; Uemoto S; Seno H
Gastroenterology; 2020 Aug; 159(2):682-696.e13. PubMed ID: 32360551
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss.
Morris SM; Baek JY; Koszarek A; Kanngurn S; Knoblaugh SE; Grady WM
Hepatology; 2012 Jan; 55(1):121-31. PubMed ID: 21898503
[TBL] [Abstract][Full Text] [Related]
14. Menin and p53 have non-synergistic effects on tumorigenesis in mice.
Loffler KA; Mould AW; Waring PM; Hayward NK; Kay GF
BMC Cancer; 2012 Jun; 12():252. PubMed ID: 22708734
[TBL] [Abstract][Full Text] [Related]
15. LGR6-dependent conditional inactivation of E-cadherin and p53 leads to invasive skin and mammary carcinomas in mice.
Ter Steege EJ; Sijnesael T; Enserink L; Klarenbeek S; Haakma WE; Bakker ERM; Derksen PWB
Neoplasia; 2023 Jan; 35():100844. PubMed ID: 36371908
[TBL] [Abstract][Full Text] [Related]
16. Genetically engineered mouse model of pleomorphic liposarcoma: Immunophenotyping and histologic characterization.
Brown JM; Patel R; Smith-Fry K; Ward M; Oliver T; Jones KB
Neoplasia; 2024 Feb; 48():100956. PubMed ID: 38199172
[TBL] [Abstract][Full Text] [Related]
17. The KrasG12D;Trp53fl/fl murine model of undifferentiated pleomorphic sarcoma is macrophage dense, lymphocyte poor, and resistant to immune checkpoint blockade.
Hildebrand KM; Singla AK; McNeil R; Marritt KL; Hildebrand KN; Zemp F; Rajwani J; Itani D; Bose P; Mahoney DJ; Jirik FR; Monument MJ
PLoS One; 2021; 16(7):e0253864. PubMed ID: 34242269
[TBL] [Abstract][Full Text] [Related]
18. Deletion of IP
Wang H; Jing R; Trexler C; Li Y; Tang H; Pan Z; Zhu S; Zhao B; Fang X; Liu J; Chen J; Ouyang K
J Gastroenterol; 2019 May; 54(5):407-418. PubMed ID: 30382364
[TBL] [Abstract][Full Text] [Related]
19. Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer.
Morton JP; Timpson P; Karim SA; Ridgway RA; Athineos D; Doyle B; Jamieson NB; Oien KA; Lowy AM; Brunton VG; Frame MC; Evans TR; Sansom OJ
Proc Natl Acad Sci U S A; 2010 Jan; 107(1):246-51. PubMed ID: 20018721
[TBL] [Abstract][Full Text] [Related]
20. Utility of LysM-cre and Cdh5-cre Driver Mice in Retinal and Brain Research: An Imaging Study Using tdTomato Reporter Mouse.
Fouda AY; Xu Z; Narayanan SP; Caldwell RW; Caldwell RB
Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):51. PubMed ID: 32232350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
